Literature DB >> 23830349

Differential caveolin-1 expression in colon carcinoma and its relation to E-cadherin-β-catenin complex.

Hanan Alsaeid Alshenawy1, Mona Abd El-Haq Abd El-Azeem Ali.   

Abstract

BACKGROUND: Colorectal cancer is the third common cancer and the second leading cause of cancer-related death in the Western world. Caveolin-1 is a new emerging prognostic marker and has different expression abilities in different cancers. The expression of caveolin-1 in colon carcinogenesis is still confusing. E-cadherin and β-catenin have a definite role in invasion and progression. Our study is designed to explore the role of caveolin-1 in cancer colon carcinogenesis and tries to elucidate the relation between its expression and E-cadherin and β-catenin expression in colon cancer.
MATERIALS AND METHODS: A total of 70 formalin-fixed, paraffin-embedded colon carcinoma specimens were studied for the expression of the 3 proteins, and a correlative study was done between each protein and different clinicopathologic parameters and between the 3 markers.
RESULTS: As the tumor becomes more aggressive and invasive and as it metastasizes, it losses the stromal caveolin-1 and E-cadherin and gains the cellular caveolin-1 and the abnormal β-catenin expression. Also, there were parallel changes between stromal caveolin-1 and E-cadherin on one side and between the cellular caveolin-1 and β-catenin on another side.
CONCLUSIONS: Our findings link caveolin-1 to the power of infiltration and spread, aggressiveness, and differentiation of cancer colon, and this may be happen through E-cadherin-β-catenin complex.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer colon; Caveolin-1; E-cadherin; β-Catenin

Mesh:

Substances:

Year:  2013        PMID: 23830349     DOI: 10.1016/j.anndiagpath.2013.05.007

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  8 in total

Review 1.  Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview.

Authors:  Samapika Routray
Journal:  Tumour Biol       Date:  2014-08-16

2.  Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma.

Authors:  Abd Al-Rahman Mohammad Foda; Mie Ali Mohammad; Azza Abdel-Aziz; Amira Kamal El-Hawary
Journal:  Tumour Biol       Date:  2015-01-27

3.  Inflammatory cytokines induce caveolin-1/β-catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway.

Authors:  Jianxi Wang; Huajiang Chen; Peng Cao; Xiaodong Wu; Fazhi Zang; Liangyu Shi; Lei Liang; Wen Yuan
Journal:  Cell Prolif       Date:  2016-04-29       Impact factor: 6.831

Review 4.  Alterations of the apical junctional complex and actin cytoskeleton and their role in colorectal cancer progression.

Authors:  Adriana Sartorio Gehren; Murilo Ramos Rocha; Waldemir Fernandes de Souza; José Andrés Morgado-Díaz
Journal:  Tissue Barriers       Date:  2015-02-23

5.  Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Pei Chen; Yu-Ling Zhang; Bai Xue; Guo-Ying Xu
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

6.  Exploring the Relationship Between Senescence and Colorectal Cancer in Prognosis, Immunity, and Treatment.

Authors:  Kechen Dong; Jianping Liu; Wei Zhou; Guanglin Zhang
Journal:  Front Genet       Date:  2022-06-15       Impact factor: 4.772

7.  CAV1 rs7804372 (T29107A) polymorphism might be a potential risk for digestive cancers: A protocol for systematic review and meta analysis.

Authors:  Pei Chen; Yu-Ling Zhang; Bai Xue; Ji-Ru Wang
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

8.  The clinicopathological significance of miR-133a in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Colin Siu-Chi Lam; Lui Ng; Ariel Ka-Man Chow; Sunny Kit-Man Wong; Hung-Sing Li; Johnny Hon-Wai Man; Oswens Siu-Hung Lo; Dominic Foo; Alvin Cheung; Thomas Yau; Jensen Tung-Chung Poon; Ronnie Tung-Ping Poon; Wai-Lun Law; Roberta Wen-Chi Pang
Journal:  Dis Markers       Date:  2014-07-01       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.